Come up with a name for your new list and we'll add to it:
Galenea raised a round of funding on October 12, 2010. Investors include
National Institute of Mental Health.
Galenea is a biopharmaceutical company discovering and developing drugs to treat schizophrenia and other central nervous system diseases. The company has developed technology, the MANTRA (Multiwell, A…